Difficulty: Medium
Average Score: 80%
Practice
Gynaecomastia may be produced after treatment with all except:
Correct answer
D
Rationale
Step-by-step rationale:
1. Gynaecomastia is a known side effect of spironolactone, digitalis, and cimetidine.
2. Rifampicin is not associated with gynaecomastia.
3. Rifampicin is an antibiotic used to treat tuberculosis and other infections.
4. The mechanism of action of rifampicin does not involve hormonal changes that could lead to gynaecomastia.
Summary of incorrect choices:
- A: Spironolactone is a potassium-sparing diuretic that can cause gynaecomastia.
- B: Digitalis (digoxin) can lead to gynaecomastia as a side effect.
- C: Cimetidine, an H2 receptor antagonist, is also known to cause gynaecomastia.
1. Gynaecomastia is a known side effect of spironolactone, digitalis, and cimetidine.
2. Rifampicin is not associated with gynaecomastia.
3. Rifampicin is an antibiotic used to treat tuberculosis and other infections.
4. The mechanism of action of rifampicin does not involve hormonal changes that could lead to gynaecomastia.
Summary of incorrect choices:
- A: Spironolactone is a potassium-sparing diuretic that can cause gynaecomastia.
- B: Digitalis (digoxin) can lead to gynaecomastia as a side effect.
- C: Cimetidine, an H2 receptor antagonist, is also known to cause gynaecomastia.